Newsletter | February 18, 2021

02.18.21 -- Achieving Success In Early-Phase Drug Development

 
Rapid Developability Assessment Of Early-Phase Molecules
 

Scaling up liquid formulations can present a number of challenges and headaches. This is especially true for complex solutions, suspensions, and emulsions, as well as biologics, sterile products, potent compounds, and sensitive APIs. In this webcast, learn about potential formulation and filling issues when transitioning a liquid formulation from feasibility through commercialization.

A Roadmap For Early Development To Commercial Manufacturing
 
Learn how to avoid common pitfalls in the transfer and scale-up process using an integrated approach, with industry experts sharing key considerations when planning for scale-up of a development program.
Patient-Centric Drug Design: A Clinical And Academic Perspective
 
Pharmacokinetic and pharmacodynamic differences can make drug development for very young patients quite challenging. One can think of pediatric medicines as one of the last uncharted frontiers in patient-centric drug development. Read about the many improvements in pediatric drug development that have occurred during the last 15 years and what is being done to continue moving forward.
Solutions